Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Taylor Y. Sadun"'
Prostate cancer multiparametric magnetic resonance imaging visibility is a tumor-intrinsic phenomena
Autor:
Amanda Khoo, Lydia Y. Liu, Taylor Y. Sadun, Amirali Salmasi, Aydin Pooli, Ely Felker, Kathleen E. Houlahan, Vladimir Ignatchenko, Steven S. Raman, Anthony E. Sisk, Robert E. Reiter, Paul C. Boutros, Thomas Kislinger
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-6 (2022)
Abstract Multiparametric magnetic resonance imaging (mpMRI) is an emerging standard for diagnosing and prognosing prostate cancer, but ~ 20% of clinically significant tumors are invisible to mpMRI, as defined by the Prostate Imaging Reporting and Dat
Externí odkaz:
https://doaj.org/article/55ecdf50c9694c1dbeb9327fbde36612
Autor:
Robert E. Reiter, Andrew T. Lenis, Jeremie Calais, Taylor Y. Sadun, David W. Johnson, Cedric Lebacle, Patrick M Lec, Matthias Eiber, Johannes Czernin, Wolfgang P. Fendler, Aydin Pooli
Publikováno v:
European Urology Oncology. 5:544-552
Background The role of prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) imaging in the initial staging of men with prostate cancer (PCa) has yet to be evaluated adequately. Objective To investigate t
Autor:
A. Lenore Ackerman, Jennifer T. Anger, Taylor Y. Sadun, Victoria Scott, Ja-Hong Kim, Melissa A. Markowitz, Lauren Wood Thum, Sally L. Maliski
Publikováno v:
Journal of Urology. 206:688-695
We investigated the perspectives of women suffering from recurrent urinary tract infections using patient focus group discussions with an emphasis on patient attitudes toward the current prevention and treatment of urinary tract infection episodes.Tw
Publikováno v:
Journal of Urology. 207
Autor:
Anthony Sisk, Robert E. Reiter, Ely Felker, Julie Livingstone, Amirali Salmasi, Preeti Ahuja, Aydin Pooli, Vincent Huang, Taylor Y. Sadun, Paul C. Boutros, Kathleen E. Houlahan, Steven S. Raman
Publikováno v:
European Urology. 76:18-23
Multiparametric magnetic resonance imaging (mpMRI) has transformed the management of localized prostate cancer by improving identification of clinically significant disease at diagnosis. Approximately 20% of primary prostate tumors are invisible to m
Autor:
Anthony Sisk, Sohrab Afshari Mirak, Ely Felker, Alexa K Hughes, Taylor Y. Sadun, Daniela Markovic, Aydin Pooli, Amirhossein Mohammadian Bajgiran, Steven S. Raman, Robert E. Reiter, David W. Johnson, Joseph Shirk
Publikováno v:
The Journal of urology. 205(2)
Oncologic efficacy of focal therapies in prostate cancer depends heavily on accurate tumor size estimation. We aim to evaluate the agreement between radiologic tumor size and pathological tumor size, and identify predictors of pathological tumor size
Autor:
Taylor Y. Sadun, Tanya B. Dorff, Robert E. Reiter, Andrea Farolfi, Oliver Sartor, Stefano Fanti
Publikováno v:
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 39
Prostate-specific membrane antigen (PSMA)–based imaging seeks to fill some critical gaps in prostate cancer staging and response assessment, and may select patients for treatment with radiolabeled PSMA conjugates. In biochemical recurrence, at pros
Autor:
Jennifer T. Anger, Taylor Y. Sadun, Victoria Scott, Ja-Hong Kim, Lauren Wood Thum, Sally L. Maliski, Melissa A. Markowitz
Publikováno v:
Journal of Urology. 201
Autor:
Sally L. Maliaski, Ja-Hong Kim, Lauren Wood Thum, Brennan M. Spiegell, Taylor Y. Sadun, Jennifer T. Anger, Victoria Scott, Gabriela Gonzalez
Publikováno v:
Journal of Urology. 201
INTRODUCTION AND OBJECTIVES:Little is known about patients’ experiences and perceptions of the current management of recurrent urinary tract infections (rUTIs). The aim of this study was to compare...
Autor:
Taylor Y. Sadun, Steven S. Raman, Preeti Ahuja, Paul C. Boutros, Ely Felker, Kathleen E. Houlahan, Aydin Pooli, Robert E. Reiter, Amirali Salmasi, Anthony Sisk
Publikováno v:
Journal of Urology. 201
INTRODUCTION AND OBJECTIVES:Multiparametric MRI (mpMRI) has transformed prostate cancer (PCa) management by improving identification of clinically significant disease. However, ∼20% of primary pros...